PR, HER2, Ki-67, and p16, but not ER and p53, displayed significantly diverse expression patterns in DCIS lesions within an individual patient, ranging from 20% to 60% of the cases (Figure 1B). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.